NCT00345319View on ClinicalTrials.gov

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

PHASE3CompletedINTERVENTIONAL

Enrollment

630

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Rabies Post-exposure Prophylaxis

Interventions

BIOLOGICAL

rabies vaccine

Administration of PCECV according to ESSEN regimen

Trial Locations (1)

Unknown

Danyang CDC, Danyang

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY

NCT00345319 - Purified Rabies Vaccine for Human Use (Chick-embryo Cell) | Biotech Hunter | Biotech Hunter